CYDY Archives - Page 7 of 7 - Blue Horseshoe Stocks

Options Updates, Fresh Plays

Options Updates:

We’re going to circle back today to highlight the performances of the options ideas we alerted on Friday morning. We selected the PRGS 07/17 $40 Calls as well as the SNX 07/17 $115-120 Calls.

In both cases, we have seen some solid moves, and with more than two weeks remaining until expiration, we’ll certainly continue to monitor their progress. Here were the figures they posted yesterday:

PRGS 07/17 $40 Calls
$40: .20-.80 (+400%)
____

SNX 07/17 $115-120 Calls
$115: 4.64-9.50 (+180%)
$120: 2.74-7.50 (+214%)

_____

Fresh Ideas:
MU 07/02 $50-51.50 Calls
CAG 07/02 $33.50-34.50 Calls

Ideanomics, Inc. IDEX

Yesterday morning we suggested that our readers give their attention to IDEX in sessions to come, and we got some modest yet notable first day results.

The stock traded up from a low of 1.65 and hit 2.30 on the day, marking an intraday swing of 39% It managed to maintain well over half of its advances, closing with strength at 2.09. This interests us more than enough to continue tracking its progress.

The company provided an update on its large electric vehicle order in a fresh PR this morning (>> Read PR)

Extended Watchlist:
CYDY, TPTW, PMCB, GOVX, PVDG,

Sustained Options Success

Options Updates
–
We try to make solid quick-strike options ideas for our readers and ourselves each and every morning. We generally do find at least some measure of success with that on a daily basis, and yesterday was no exception to that.

We signaled a range of bullish ideas for CAH, in addition to a bearish one for MAR which both turned in some decent gains on the day. A few of the longer term ideas we’ve been tracking saw increases as well, but we’ll come back to those at a later time.

For now, here are the moves made by yesterday’s targets so far:

CAH Weekly $52.50-54 Calls
$52.50: .90-2.20 (+144%)
$53: .71-1.68 (+135%)
$53.50: .55-1.30 (+136%)
$54: .30-1.15 (+283%)

_____

MAR Weekly $86.50-85 Puts
$86.50: 3.98-5.24 (+32%)
$86: 3.40-5.15 (+51%)
$85.50: 4.10-5.00 (+22%)
$85: 2.80-4.50 (+61%)

More Fresh Ideas:
MCY 06/19 $35-45 Calls
SPG Weekly $55-65 Calls
GWPH Weekly $110-115 Calls
NVAX 05/22 $38-40 Calls

Extended Watchlist:
BSGM, KTOV, NSPR, LUVU, VYST, CYDY, BTCS, GBTC

Sticking with SPY Puts

Solid Hits on the SPY

We try to formulate new options ideas for a given session as often as we can without forcing the issue, and on most days we produce at least one. Yesterday, we designated our sole set of new contracts to watch as the SPY Weekly $250-248 Puts, and thanks to a painful day for the markets, we were afforded the chance to score some pretty nice intraday gains.

Two out of three of those strike points translated into instant double-bag opportunities, with the third falling just 1% short of that mark, providing the following moves on the day:

SPY Weekly $250-248 Puts
$250: 4.39-8.73 (+99%)
$249: 4.00-8.10 (+103%)
$248: 3.65-7.50 (+105%)
______

Fresh Ideas:
SPY Weekly $244-242 Puts
WBA Weekly $44-45 Calls
KMX Weekly $50-55 Calls

CytoDyn, Inc. CYDY

We began tracking CYDY on Tuesday morning, and in addition to making a nominal move on the chart, the company has also put out some coronavirus related press in the couple days. One of the company’s investigational drugs which is about to enter Phase 2b/3 trials, has demonstrated a promising level of efficacy among severe COVID-19 patients.

The stock itself has run from 2.65-3.09 in the past couple of sessions, which marks a move of just 17% but we’re going to be interested to continue tracking its performance in light of the company’s announcements.

VANCOUVER, Washington, April 02, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the three-day effect of leronlimab in eight severely ill COVID-19 patients demonstrated a significant improvement in several important immunologic bio-markers. Patient test data reveals improvement in cytokines, IL-6, and a trend toward the normalization of the CD4/CD8 ratio. (>>View Full PR)

Extended Watchlist:
GRYO, PNAT, ROTH, SOLI, CTYX, IPIX

Reviewing Winning Ideas, Formulating New Ones

Johnson & Johnson JNJ

We were correct in assuming yesterday would be a good day to put some options trading ideas for Johnson & Johnson on the table. The company is now at the center of the frantic pursuit of a vaccine to eradicate the deadly COVID-19 virus. We expect we will be following its role in this endeavor to completion.

For now, while we have signaled some longer-term options as well, we’re mainly interested in the short term plays we’re tracking and the moves they began to make yesterday. We will include the modest moves made by our September calls, but would expect to have to wait for them to come into play in a more meaningful way.

JNJ Weekly $125-130 Calls
$125: 5.15-9.81 (+90%)
$126: 4.00-9.00 (+125%)
$127: 4.00-8.00 (+100%)
$128: 2.95-7.37 (+150%)
$129: 2.86-6.65 (+133%)
$130: 2.45-5.96 (+143%)

09/18 $150-155 Calls
$150: 3.50-5.00 (+43%)
$155: 2.80-3.50 (+25%)

Top Ships, Inc. TOPS

Our chatroom call from Friday, which we highlighted in yesterday morning’s premarket report, tacked considerable gains onto our observed range after another huge bullish session. It saw a daily run from .36 to a new high of .62, which comes out to an intraday increase of 72%

From the low of .135 that TOPS saw on Friday morning when we offered it to our traders chat participants, yesterday’s new high mark represented a two-day upswing of 359% We’re seeing a significant pullback in the stock this morning, so this run has had it, but we’ll keep an eye skinned as it searches out a bottom, as a another swing to the upside may follow shortly thereafter.

Anyone who enjoys our premarket reports can also join our daily traders chats on Skype. It’s a place to get new ideas and even share some of your own in real-time throughout the course of each trading day. Send a Skype contact request to username “stocksumo” and we’ll see you there!

Streaming Stocks

More people are at home streaming content than ever before, and that is going to be true throughout the duration of the coronavirus crisis, which most experts agree will persist until a vaccine is successfully produced, sometime in 2021. Here are a couple of obvious players who stand to maintain solid business through this new dynamic, and some corresponding ideas.

ROKU Weekly $87.50-89 Calls
NFLX $365-372.50 Calls

Extended Watchlist:
HALB, NSPX, ABCE, BIEI, CYDY, SPHS,